Sealant could cut wrist compression time after heart procedures
NCT ID NCT07768839
First seen Aug 17, 2026 · Last updated Aug 18, 2026 · Updated 1 time
Summary
This trial tests whether adding a potassium ferrate sealant to the standard wrist compression device can stop bleeding faster after coronary angiography or PCI. About 300 adults undergoing these procedures will be randomly assigned to receive the sealant plus the device or the device alone. The goal is to see if the sealant allows the compression band to be removed sooner, which could lead to earlier discharge and a quicker recovery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Potassium ferrate hemostatic sealant (PFHS) applied at the wrist puncture site, plus a pneumatic radial compression device
- What this could lead to
- If effective, this could shorten the time patients need wrist compression after heart catheterization, allowing earlier discharge and faster recovery.
- What could go wrong
- The trial is early and single-center, so results may not apply broadly. Risks include bleeding, bruising, or allergic reactions at the puncture site.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2032
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years • Undergoing trans radial coronary angiography with or without PCI * Radial 6Fr Prelude sheath used for the procedure * Planned use of Inflation band (Sunny Medical) radial compression device for hemostasis * Able to provide informed consent * Adequate collateral circulation per institutional radial access screening (consistent with device contraindications). Exclusion Criteria: * On a GPIIB/IIIA inhibitor * Known hypersensitivity to device materials * Infection or serious skin disease at puncture site * Abnormal collateral circulation test / insufficient dual arterial supply * Inability to complete study assessments before discharge * Conversion to femoral access or need for alternate hemostasis device * Prior radial artery harvest or known chronic radial artery occlusion in the study limb (per operator judgement).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coronary angiogram are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.